Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Christophe Weber
Pharma
Daiichi-Merck, Wegovy, Takeda CEO—Fierce Pharma Asia
The FDA rejected Daiichi and Merck's antibody-drug conjugate. Novo's Wegovy won its China nod. Takeda CEO is still open to China deal. Plus more.
Angus Liu
Jun 28, 2024 8:40am
Takeda focuses on Qdenga as it braces for Vyvanse generics
Jul 27, 2023 1:38pm
Takeda expects patent expirations to weigh on earnings
May 12, 2023 11:10am
Takeda expands manufacturing in preparation for Qdenga launch
Jan 10, 2023 10:17am
Velcade sales halved at Takeda amid multiple US generic entries
Jul 28, 2022 11:34am
Takeda, Biogen-Samsung, Astellas and more—Fierce Pharma Asia
Jun 3, 2022 10:05am